Did Canopy Growth Corp. Stock Trade Contrary to Popular Opinion Last Week?

Here’s why listing on a major U.S. exchange did not deliver much for Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) stock last Thursday.

Investors may have anticipated a rally in Canopy Growth Corp. (TSX: WEED)(NYSE:CGC) stock on May 24, as the eldest-listed Canadian cannabis company’s equity units debuted trading on the New York Stock Exchange, but there wasn’t to be as much joy for its investors as there was for Cronos Group Inc. (TSX: CRON)(NASDAQ: CRON) investors when it listed on the NASDAQ market in February.

Cronos Group stock rallied as much as 36% in its first week of trading the NASDAQ, as American investors welcomed a marijuana listing on a major U.S. exchange for the first time ever, and it was to be expected that a similar move by the world’s biggest pot company by market capitalization could produce similar results.

Unfortunately, this was not to be.

Canopy’s common equity units did not rally on their maiden trading day on a U.S exchange. The valuation went south instead, and their trading price closed 6.2% lower on the TSX. Recovery attempts were not fruitful on the following day either, as the CGC ticker closed down 4.1% on the NYSE on May 25.

Should this be surprising?

While a downward trend on Canopy stock was not something to be anticipated after making a major move to the NASDAQ, the failure to take off as new institutional and individual investors take positions on a previously inaccessible stock may not be that surprising.

As previously discussed on March 13, Canopy common equity units have been too broadly traded, and the company has enjoyed so much investor awareness since it debuted trading as the first listed marijuana stock, the first cannabis play to list on the main TSX exchange — a major North American exchange — and the first marijuana play to be included in the S&P/TSX Composite index — a major performance benchmark for most Canadian institutional money managers.

Given the above background, there was much to gain for Cronos investors due to the added publicity and accessibility to U.S. investors, as the company listed its equity on NASDAQ, but the same could not be anticipated for Canopy units.

Canopy shares recorded some valuation gains since the company announced its application to list on the NYSE on May 14, and some investors may have bought the rumour in anticipation of selling the news when the shares finally started trading on the NYSE, hence the potential selling pressure on Canopy’s maiden trading day in New York.

That said, we can’t isolate the effect on Canopy’s valuation due to the NYSE listing plans, as there were some several other announcements affecting valuations during the period to May 24.

Investor takeaway

While marijuana plays are mostly speculative trades, cannabis investors should never bank on rallies fueled by trading environment changes alone; betting on fundamentals growth makes for a sound investment play on the nascent industry.

Cronos Group was venturing into more the limelight when it listed in the U.S., while Canopy has been basking in the same since it debuted trading on the TSX, became included in a major world equity index, all the while being the largest marijuana stock by market capitalization in the world, thus giving the company high investor market exposure.

We cannot therefore anticipate that Canopy’s valuation will rise as high as that of Cronos Group upon a U.S. listing. However, the units are trading higher today, as investors price in the announcement made on Sunday, that the company was awarded its 10th cannabis production licence.

Fool contributor Brian Paradza has no position in any of the stocks mentioned.

More on Investing

how to save money
Energy Stocks

Want $12,000 a Year in Dividends? Here’s the Capital the Goal Requires

A $12,000 dividend target can look more manageable once you see the required balance and how much monthly deposits can…

Read more »

investor looks at volatility chart
Dividend Stocks

2 Discounted TSX Dividend Stocks That Could Rebound in 2027

Two TSX dividend stocks currently trading at deep discounts are well-positioned to stage a strong rebound in 2027.

Read more »

people sit in two wooden beach chairs facing the Caribbean ocean holding drinks and making a toast
Dividend Stocks

How to Build $5,000 in Tax-Free Passive Income in Your TFSA

Building $5,000 in tax-free Income in your TFSA over time is possible with the right portfolio mix and reinvestment of…

Read more »

ETFs can contain investments such as stocks
Dividend Stocks

2 Easy ETFs to Build Long-Term Wealth

Investing in a pair of established ETFs to save for retirement or build long-term wealth can ease the burden of…

Read more »

Bank of Canada Governor Tiff Macklem
Dividend Stocks

Bank of Canada Rate Hikes Could Shift the GIC vs. Dividend Stock Equation

Fortis Inc (TSX:FTS) is highly indebted. It benefits when rates go down.

Read more »

Offshore wind turbine farm at sunset
Energy Stocks

Northland Power Stock: Would I Buy the Dividend or Wait for Better Cash Flow?

Northland pays monthly after cutting its dividend. I’d wait for more cash after project spending before giving it a job…

Read more »

dividend stocks are a good way to earn passive income
Dividend Stocks

Enbridge vs. Telus: Which Stock Offers More Reliable Income Through 2030?

Enbridge and Telus are two of the best Canadian dividend stocks on the TSX, but which is the better hold…

Read more »

cloud computing
Dividend Stocks

Intact vs. Fairfax: Which Insurance Stock Fits a More Conservative Portfolio?

Both companies can earn money from insurance and investments. I’d pick Intact if I want a simpler way to follow…

Read more »